Background To assess the impact of a quadrivalent human papillomavirus vaccine (4HPV)
in women at increased risk of genital warts (GWs) acquisition. Methods The study was …

Background The quadrivalent human papillomavirus (HPV) vaccine has been assumed to
give protection against genital warts (GW) as well as cervical cancer. Our main question was …

Background Increasing evidence suggests that 1-dose human papillomavirus (HPV)
vaccination may protect significantly against HPV-related disease. We provide nationwide …

Background The objective was to evaluate the effect of a HPV vaccination program on the
incidence proportion of a proxy, genital warts (GW), in women in France. Methods: The …

Objective Genital warts are the most common sexually transmitted disease and have a
detrimental impact on quality of life. Genital warts could be prevented by prophylactic HPV …

Genital warts (GWs) are common, with about 5% to 10% of people having at least one
episode in their lifetime. They develop about 2–3 months after infection with human …

Background There is ongoing debate about the possible protective effect of the bivalent
human papillomavirus (2vHPV) vaccine, targeting oncogenic types HPV-16/18, against …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts (GW)
in women aged 14–23 years and to estimate the incidence of GW in the whole population …

Background. More than 90% of genital warts (GW) cases are caused by human
papillomavirus (HPV) types 6 and 11. The introduction of HPV vaccines necessitates the …

Background Approximately 90% of genital warts (GWs) are caused by human
papillomavirus (HPV) types 6 and 11. Denmark has provided the quadrivalent HPV vaccine …